{"disease":{"id":"muc17-positive-solid-tumors","name":"muc17 positive solid tumors"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04117958","title":"Study of AMG 199 in Subjects With MUC17-Positive Solid Tumors Including Gastric, Gastroesophageal Junction, Colorectal, and Pancreatic Cancers","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":58,"lead_sponsor_name":"Amgen","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}